China NMPA Product Recall - Sp02 Patient Monitoring System

The National Medical Products Administration (NMPA) has announced a Class I voluntary recall initiated by Covidien LLC, with reporting handled by Covidien Medical Devices International Trading (Shanghai) Co., Ltd. This recall, published on July 10, 2025, addresses a significant safety concern related to the Sp02 Patient Monitoring System, also referred to as a Pulse Oxygen Saturation Meter (National Medical Device Registration Certificate 20152072123). The primary issue prompting this high-level recall is the potential for undetected alarms during the device's operation. This critical flaw poses a direct risk of patient injury, necessitating immediate corrective action to safeguard public health. A Class I recall designation indicates that there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death. As a required action, Covidien LLC is undertaking a voluntary recall of the affected product models, specifications, and batch numbers, with detailed information available in the "Medical Device Recall Event Report Form." This measure is in accordance with NMPA's regulatory framework for medical device safety, ensuring that products posing serious risks are promptly removed from circulation. The company is responsible for notifying affected customers and facilitating the return or replacement of the devices to mitigate any further potential harm. The NMPA oversees this process to ensure compliance and patient safety.